Advancements and challenges of R-loops in cancers: Biological insights and future directions
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2024.217359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025. Verfasst von Dengxiong Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Neoplasms, R-Loop Structures. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 194 Literaturangaben. Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
R-loops involve in various biological processes under human normal physiological conditions. Disruption of R-loops can lead to disease onset and affect the progression of illnesses, particularly in cancers. Herein, we summarized and discussed the regulative networks, phenotypes and future directions of R-loops in cancers. In this review, we highlighted the following insights: (1) R-loops significantly influence cancer development, progression and treatment efficiency by regulating key genes, such as PARPs, BRCA1/2, sex hormone receptors, DHX9, and TOP1. (2) Currently, the ATM, ATR, cGAS/STING, and noncanonical pathways are the main pathways that involve in the regulatory network of R-loops in cancer. (3) Cancer biology can be modulated by R-loops-regulated phenotypes, including RNA methylation, DNA and histone methylation, oxidative stress, immune and inflammation regulation, and senescence. (4) Regulation of R-loops induces kinds of drug resistance in various cancers, suggesting that targeting R-loops maybe a promising way to overcome treatment resistance. (5) The role of R-loops in tumorigenesis remains controversial, and senescence may be a crucial research direction to unravel the mechanism of R-loop-induced tumorigenesis. Looking forward, further studies are needed to elucidate the specific mechanisms of R-loops in cancer, laying the groundwork for preclinical and clinical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
- Department of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo City, Zhejiang Province, 315211, China.
- Department of Urology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, 47907, USA; Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN, USA.
- Department of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Förderung
- China Scholarship Council
Zitieren
APA
Li, D., Shao, F., Li, X., Yu, Q., Wu, R., Wang, J., Wang, Z., Wusiman, D., Ye, L., Guo, Y., Tuo, Z., Wei, W., Yoo, K. H., Cho, W. C., & Feng, D. (2025). Advancements and challenges of R-loops in cancers: Biological insights and future directions. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217359
Vancouver
Li D, Shao F, Li X, Yu Q, Wu R, Wang J, et al. Advancements and challenges of R-loops in cancers: Biological insights and future directions. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217359
BibTeX
@article{Li2025,
author = {Li, Dengxiong and Shao, Fanglin and Li, Xinrui and Yu, Qingxin and Wu, Ruicheng and Wang, Jie and Wang, Zhipeng and Wusiman, Dilinaer and Ye, Luxia and Guo, Yiqing and Tuo, Zhouting and Wei, Wuran and Yoo, Koo Han and Cho, William C and Feng, Dechao},
title = {Advancements and challenges of R-loops in cancers: Biological insights and future directions},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2024.217359}
}
EUVIMED